SGE-301 was a gift from Sage Therapeutics (Cambridge, MA) (Paul et al., 2013). Other chemicals were purchased from Sigma Chemical Company (St. Louis, MO). For ex vivo slice experiments, SGE-301 or 24S-HC was dissolved in DMSO and administered at concentrations noted in the text. The concentration of DMSO was typically 0.1% and has no effect on hippocampal responses or synaptic plasticity (Izumi and Zorumski, 2020; Popiolek et al., 2020). For in vivo experiments, 5 mg SGE-301 was dissolved in 3.3 ml of 2-hydroxypropyl-β-cyclodextrin (CDX) (catalog number 332607; Sigma) (1.5 g CDX + 3 ml water) and administered at a final dose of 3 mg/kg i.p. This dose of SGE-301 was selected based on prior behavioral studies we have done with this agent (Paul et al., 2013).

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.